BETNESOL RETENTION ENEMA 5MG/100ML DIN 02060884
Status: Cancelled Post Market
Holder: PALADIN PHARMA INC.
Health Canada record
| Active ingredient(s) | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 5 MG |
|---|---|
| Dosage form | Enema |
| Route | Rectal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A07EA04 BETAMETHASONE |
| Original market date | 01-Apr-1997 |
| Current status date | 27-Jun-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Paladin Pharma Inc. — licence 100234, currently licensed, last inspection rating C (2023-04-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02063190 | BETNESOL TABLETS | SHIRE PHARMA CANADA ULC | Tablet (Effervescent) | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 0.5 MG | Cancelled Post Market |
| 00176834 | CELESTONE REPETABS 1MG | SCHERING-PLOUGH CANADA INC | Tablet (Extended-Release) | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG | Cancelled Post Market |
| 02238818 | DOM-GENTAMICIN-BETAMETHASONE | DOMINION PHARMACAL | Liquid | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Pre Market |
| 00682217 | GARASONE OPHTHALMIC AND OTIC SOLUTION | MERCK CANADA INC | Solution | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 00586706 | GARASONE OPHTHALMIC OINTMENT | MERCK CANADA INC | Ointment | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market |
| 02238819 | PMS-GENTAMICIN-BETAMETHASONE | PHARMASCIENCE INC | Liquid | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10216 | 2009-05-15 | New Drug Submission (NDS) | Manufacturer name change |
| 8807 | 2007-06-01 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |